# FDA Inspection 1028754 - Implant Direct Sybron International, LLC - September 26, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/implant-direct-sybron-international-llc/881c8c21-0fc4-4ce7-a60f-49885f73b0af
Source feed: FDA_Inspections

> FDA Inspection 1028754 for Implant Direct Sybron International, LLC on September 26, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028754
- Company Name: Implant Direct Sybron International, LLC
- Inspection Date: 2017-09-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 988719 - 2016-08-29](https://www.globalkeysolutions.net/records/fda_inspections/implant-direct-sybron-international-llc/eb18bade-1e60-46b3-a5fa-daf5a2103e14)
- [FDA Inspection 982340 - 2016-06-28](https://www.globalkeysolutions.net/records/fda_inspections/implant-direct-sybron-international-llc/6a61471f-26c4-4cc9-8387-89e56babdbac)
- [FDA Inspection 891481 - 2014-08-07](https://www.globalkeysolutions.net/records/fda_inspections/implant-direct-sybron-international-llc/46203e55-b967-43b8-bf79-29e5c5d324d3)

Company: https://www.globalkeysolutions.net/companies/implant-direct-sybron-international-llc/484fcb7c-406d-4a2e-9056-486a8496908b

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d